Perbedaan Diagnos Laboratorium Utama Tbk. dan Kentanix Supra International Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,7 rb), sedangkan Kentanix Supra International Tbk. diperdagangkan di Rp408 (kapitalisasi pasar 880,79 M, volume 24 jam 367,7 rb). Perbedaan utamanya: Kentanix Supra International Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Kentanix Supra International Tbk. lebih aktif diperdagangkan (367,7 rb vs 41,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | KSIX | |
|---|---|---|
Kapitalisasi Pasar | 316,25 M | 880,79 M |
Volume | 41,7 rb | 367,7 rb |
Lot | 417 | 3,68 rb |
Perputaran | 9,66 jt | 147,39 jt |
Harga Rata-rata | 231,65 | 400,85 |
Nilai Transaksi | 9,66 jt | 147,39 jt |
Harga Ekuilibrium Indikatif | 230 | 408 |
Volume Ekuilibrium Indikatif | 2,4 rb | 17 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Selengkapnya di halaman KSIX →